Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

8

Number of overlapping holdings

16.0%

% of CANC's 50 holdings also in PBE

28.6%

% of PBE's 28 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus PBE)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in PBE
Overlap
EXELIXIS INC 4.1% 3.0% 3.0%
AMGEN INC 3.0% 5.7% 3.0%
BLUEPRINT MEDICINES CORP. 2.7% 2.6% 2.6%
GILEAD SCIENCES INC 1.9% 6.7% 1.9%
REGENERON PHARMACEUTICALS 1.1% 4.9% 1.1%

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to PBE
ELI LILLY & CO 5.4%
ROCHE HOLDINGS LTD-SPONS ADR 5.2%
REVOLUTION MEDICINES, INC. 5.1%
BRISTOL-MYERS SQUIBB CO 4.5%
ASTRAZENECA PLC 4.5%
NOVARTIS AG 4.1%
GENMAB A/S SPONSORED ADR 3.7%
BRIDGEBIO PHARMA, INC. 3.6%
NUVALENT, INC. CLASS A 3.6%
CHUGAI PHARMACEUTICAL CO LTD 3.1%
CANC Underweight Relative to PBE
BIOGEN IDEC INC -4.9%
GILEAD SCIENCES INC -4.8%
UNITED THERAPEUTICS CORP -4.5%
NATERA INC -4.4%
INCYTE CORP -4.2%
REGENERON PHARMACEUTICALS -3.8%
HALOZYME THERAPEUTICS INC -3.6%
AXSOME THERAPEUTICS, INC. -3.6%
ROYALTY PHARMA PLC CLASS A -3.5%
TG THERAPEUTICS INC -3.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY